ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,221.42
-0.02%
Dow Jones
39,431.51
-0.21%
US Dollar vs MXN
16.7763
-0.13%
Brent Oil
82.905
-0.37%
Bitcoin
61,831.88
-1.70%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
14/05/202406:30GlobeNewswire Inc.Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
14/05/202406:30GlobeNewswire Inc.Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial ResultsNASDAQ:XLOXilio Therapeutics Inc
14/05/202406:30GlobeNewswire Inc.Alimera Sciences Reports First Quarter 2024 ResultsNASDAQ:ALIMAlimera Sciences Inc
14/05/202406:30GlobeNewswire Inc.MiNK Reports First Quarter 2024 ResultsNASDAQ:INKTMiNK Therapeutics Inc
14/05/202406:30GlobeNewswire Inc.BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2024NASDAQ:BBIOBridgeBio Pharma Inc
14/05/202406:30GlobeNewswire Inc.Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital RaiseMDG1
14/05/202406:30GlobeNewswire Inc.XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQNASDAQ:XOMAOXOMA Corporation
14/05/202406:30GlobeNewswire Inc.2024 Rabbet Report: Risk Management and Automation Emerge as Top Priorities in Construction Finance
14/05/202406:30Business WireSyros Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:SYRSSyros Pharmaceuticals Inc
14/05/202406:30GlobeNewswire Inc.Kroma Announces Spectrum’s Launch Alongside Expansion Plans
14/05/202406:30Business WireCybin to Participate in the Alliance Global Partners Healthcare Company Showcase
14/05/202406:30Business WireSmith Douglas Homes Reports First Quarter 2024 ResultsNYSE:SDHCSmith Douglas Homes Corp
14/05/202406:30GlobeNewswire Inc.nCino Announces Timing of its First Quarter Fiscal Year 2025 Financial Results Conference Call
14/05/202406:30GlobeNewswire Inc.ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic ProcessNYSE:WTWisdomTree Inc
14/05/202406:30GlobeNewswire Inc.Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateNASDAQ:GANXGain Therapeutics Inc
14/05/202406:30GlobeNewswire Inc.Entourage Health to Hold First Quarter 2024 Financial Results Call on May 284WE0.F
14/05/202406:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
14/05/202406:30Business WireCTCL Global Care Collaborative Pioneers Consensus for Improving Diagnosis and Care in Cutaneous T-Cell Lymphoma (CTCL)
14/05/202406:30Business WireSolarWinds Unveils Enhanced Database Performance Analyzer with Advanced PostgreSQL SupportNYSE:SWISolarWinds Corporation
14/05/202406:30GlobeNewswire Inc.Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
14/05/202406:30GlobeNewswire Inc.NowVertical Welcomes David Doritty as Independent DirectorTSXV:NOWNowVertical Group Inc
14/05/202406:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQNASDAQ:AVXLAnavex Life Sciences Corporation
14/05/202406:30GlobeNewswire Inc.HealthEquity Closes Acquisition of BenefitWallet HSA PortfolioNASDAQ:HQYHealthEquity Inc
14/05/202406:30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
14/05/202406:30GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment PlanTSX:PRNProfound Medical Corp
14/05/202406:30Business WireZai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in ChinaNASDAQ:ZLABZai Lab Ltd
14/05/202406:30Business WireAccelera by Cummins and Isuzu will Collaborate on Battery Packs for Light Duty VehiclesNYSE:CMICummins Inc
14/05/202406:30GlobeNewswire Inc.FitLife Brands Announces First Quarter 2024 ResultsNASDAQ:FTLFFitLife Brands Inc
14/05/202406:30GlobeNewswire Inc.Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AMLNASDAQ:KURAKura Oncology Inc
14/05/202406:30GlobeNewswire Inc.Batteh Named Saia’s Chief Financial OfficerNASDAQ:SAIASaia Inc

Su Consulta Reciente

AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
AMEX
XLF
Financial Select Sector
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados